Thoratec

Rank: 86
2015 Rank93
Employees1,048
Revenue:$477,560,000
R&D Spend:$105,475,000
Fiscal year ending:01/03/15
Click here to see all 100

Thoratec is a developer in mechanical circulatory support with the broadest product portfolio to treat the full range of clinical needs for patients suffering from advanced heart failure. The company's products include the HeartMate LVAS and Thoratec VAD, with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and markets the CentriMag and PediMag / PediVAS product lines. Thoratec is headquartered in Pleasanton, California with facilities in Burlington, Massachusetts; Rancho Cordova, Sunnyvale California; Ann Arbor, Michigan; Huntingdon, Cambridgeshire, UK; and Zurich, Switzerland.

St. Jude Medical Completes Acquisition of Thoratec. HeartMate 3 CE Mark Trial Meets Primary Endpoint. Thoratec Issues Voluntary Device Correction. Thoratec Receives Conditional FDA Approval For The Shield II U.S. Clinical Trial For HeartMate PHP. Thoratec Receives Approval From FDA For Full Expansion Of HeartMate III™ U.S. IDE Clinical Trial.

2015 Top 500 Solar Contractors Key Personnel: Keith Grossman, President & CEO; Taylor Harris, VP & CFO; David Lehman, SVP & General Counsel; Vassant Padmanabhan, SVP, IT; Niamh Pellegrini, President, Sales;

6035 Stoneridge Dr
Pleasanton, California
94588
USA